Selected Publications
Zhou P, Shi H, Huang H, Sun X, Yuan S, Chapman NM, Connelly JP, Lim SA, Saravia J, Kc A, Pruett-Miller SM, Chi H. Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer. Nature Dec;624(7990):154-163, 2023. doi: 10.1038/s41586-023-06733-x. Epub 2023 Nov 15. PMID: 37968405
Lee HM, Wright WC, Pan M, Low J, Currier D, Fang J, Singh S, Nance S, Delahunty I, Kim Y, Chapple RH, Zhang Y, Liu X, Steele JA, Qi J, Pruett-Miller SM, Easton J, Chen T, Yang J, Durbin AD, Geeleher P. A CRISPR-drug perturbational map for identifying compounds to combine with commonly used chemotherapeutics. Nat Commun Nov 13;14(1):7332, 2023. doi: 10.1038/s41467-023-43134-0.PMID: 37957169
Chen YH, Connelly JP, Florian C, Cui X, Pruett-Miller SM. Short tandem repeat profiling via next-generation sequencing for cell line authentication. Dis Model Mech Oct 1;16(10):dmm050150, 2023. doi: 10.1242/dmm.050150. Epub 2023 Oct 23. PMID: 37712227
Fang J, Singh S, Cheng C, Natarajan S, Sheppard H, Abu-Zaid A, Durbin AD, Lee HW, Wu Q, Steele J, Connelly JP, Jin H, Chen W, Fan Y, Pruett-Miller SM, Rehg JE, Koo SC, Santiago T, Emmons J, Cairo S, Wang R, Glazer ES, Murphy AJ, Chen T, Davidoff AM, Armengol C, Easton J, Chen X, Yang J. Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma. Nat Commun Jul 6;14(1):4003, 2023. doi: 10.1038/s41467-023-39717-6. PMID: 37414763
Mayuranathan T, Newby GA, Feng R, Yao Y, Mayberry KD, Lazzarotto CR, Li Y, Levine RM, Nimmagadda N, Dempsey E, Kang G, Porter SN, Doerfler PA, Zhang J, Jang Y, Chen J, Bell HW, Crossley M, Bhoopalan SV, Sharma A, Tisdale JF, Pruett-Miller SM, Cheng Y, Tsai SQ, Liu DR, Weiss MJ, Yen JS. Potent and uniform fetal hemoglobin induction via base editing. Nat Genet Jul;55(7):1210-1220, 2023. doi: 10.1038/s41588-023-01434-7. Epub 2023 Jul 3. PMID: 37400614
Malireddi RKS, Bynigeri RR, Mall R, Nadendla EK, Connelly JP, Pruett-Miller SM, Kanneganti TD. Whole-genome CRISPR screen identifies RAVER1 as a key regulator of RIPK1-mediated inflammatory cell death, PANoptosis. iScience May 22;26(6):106938, 2023. doi: 10.1016/j.isci.2023.106938. eCollection 2023 Jun 16. PMID: 37324531
Liu Y, Klein J, Bajpai R, Dong L, Tran Q, Kolekar P, Smith JL, Ries RE, Huang BJ, Wang YC, Alonzo TA, Tian L, Mulder HL, Shaw TI, Ma J, Walsh MP, Song G, Westover T, Autry RJ, Gout AM, Wheeler DA, Wan S, Wu G, Yang JJ, Evans WE, Loh M, Easton J, Zhang J, Klco JM, Meshinchi S, Brown PA, Pruett-Miller SM, Ma X. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication. Nat Commun Apr 5;14(1):1739, 2023. doi: 10.1038/s41467-023-37438-4. PMID: 37019972
Narina S, Connelly JP, Pruett-Miller SM. High-Throughput Analysis of CRISPR-Cas9 Editing Outcomes in Cell and Animal Models Using CRIS.py. Methods Mol Biol 2631:155-182, 2023. doi: 10.1007/978-1-0716-2990-1_6. PMID: 36995667
Adriaanse FRS, Kamens JL, Vogel P, Sakurada SM, Pruett-Miller SM, Stam RW, Michel Zwaan C, Gruber TA. A CRISPR/Cas9 engineered MplS504N mouse model recapitulates human myelofibrosis. Leukemia Oct;36(10):2535-2538, 2022. doi: 10.1038/s41375-022-01684-0. Epub 2022 Aug 23. PMID: 3599926
Long L, Wei J, Lim SA, Raynor JL, Shi H, Connelly JP, Wang H, Guy C, Xie B, Chapman NM, Fu G, Wang Y, Huang H, Su W, Saravia J, Risch I, Wang YD, Li Y, Niu M, Dhungana Y, Kc A, Zhou P, Vogel P, Yu J, Pruett-Miller SM, Peng J, Chi H. CRISPR screens unveil signal hubs for nutrient licensing of T cell immunity. Nature Dec;600(7888):308-313, 2021. doi: 10.1038/s41586-021-04109-7. Epub 2021 Nov 18. PMID: 34795452
Newby GA, Yen JS, Woodard KJ, Mayuranathan T, Lazzarotto CR, Li Y, Sheppard-Tillman H, Porter SN, Yao Y, Mayberry K, Everette KA, Jang Y, Podracky CJ, Thaman E, Lechauve C, Sharma A, Henderson JM, Richter MF, Zhao KT, Miller SM, Wang T, Koblan LW, McCaffrey AP, Tisdale JF, Kalfa TA, Pruett-Miller SM, Tsai SQ, Weiss MJ, Liu DR. Base editing of haematopoietic stem cells rescues sickle cell disease in mice. Nature Jul;595(7866):295-302, 2021. doi: 10.1038/s41586-021-03609-w. Epub 2021 Jun 2. PMID: 34079130
Cheng X, Peters ST, Pruett-Miller SM, Saunders TL, Joe B. In Vivo CRISPR/Cas9-Based Targeted Disruption and Knockin of a Long Noncoding RNA. Methods Mol Biol 2021;2254:305-321, 2021. doi: 10.1007/978-1-0716-1158-6_19. PMID: 33326084
Cheng X, Peters ST, Pruett-Miller SM, Saunders TL, Joe B. In Vivo CRISPR/Cas9-Based Targeted Disruption and Knockin of a Long Noncoding RNA. Methods Mol Biol 2254:305-321, 2021. doi: 10.1007/978-1-0716-1158-6_19. PMID: 33326084
Pruett-Miller SM. Cancer Screens: Better Together. CRISPR J Feb;3(1):12-14, 2020. doi: 10.1089/crispr.2020.29084.spm. PMID: 32091251
Demirci S, Zeng J, Wu Y, Uchida N, Shen AH, Pellin D, Gamer J, Yapundich M, Drysdale C, Bonanno J, Bonifacino AC, Krouse AE, Linde NS, Engels T, Donahue RE, Haro-Mora JJ, Leonard A, Nassehi T, Luk K, Porter SN, Lazzarotto CR, Tsai SQ, Weiss MJ, Pruett-Miller SM, Wolfe SA, Bauer DE, Tisdale JF. BCL11A enhancer-edited hematopoietic stem cells persist in rhesus monkeys without toxicity. J Clin Invest Dec 1;130(12):6677-6687, 2020. doi: 10.1172/JCI140189.PMID: 32897878
Pruett-Miller SM. Assessing Off-Target Editing of CRISPR-Cas9 Systems. CRISPR J Dec;3(6):430-432, 2020. doi: 10.1089/crispr.2020.29116.smi. PMID: 33346715
Papizan JB, Porter SN, Sharma A, Pruett-Miller SM. Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies. J Biomed Res Nov 9;35(2):115-134, 2020. doi: 10.7555/JBR.34.20200096. PMID: 33349624
Wagner J, Wickman E, Shaw TI, Allo Anido A, Langfitt D, Zhang J, Porter SN, Pruett-Miller SM, Tillman H, Krenciute G, Gottschalk S Antitumor effects of CAR T cells redirected to the EDB splice variant of fibronectin. Cancer Immunol Res Dec 22:canimm.0280.2020, 2020. doi: 10.1158/2326-6066.CIR-20-0280. Online ahead of print. PMID: 3335518832.
Smith KH, Budhraja A, Lynch J, Roberts K, Panetta JC, Connelly JP, Turnis ME, Pruett-Miller SM, Schuetz JD, Mullighan CG, Opferman JT. The Heme-regulated Inhibitor Pathway Modulates Susceptibility of Poor Prognosis B-Lineage Acute Leukemia to BH3-Mimetics. Mol Cancer Res Dec 7:molcanres.0586.2020, 2020. doi: 10.1158/1541-7786.MCR-20-0586. Online ahead of print. PMID: 33288732
**Pruett-Miller SM. Assessing Off-Target Editing of CRISPR-Cas9 Systems. CRISPR J Dec;3(6):430-432, 2020. doi: 10.1089/crispr.2020.29116.smi. PMID: 33346715
Xu P, Scott DC, Xu B, Yao Y, Feng R, Cheng L, Mayberry K, Bi W, Palmer LE, King MT, Wang H, Li Y, Fan Y, Alpi AF, Li C, Peng J, Papizan J, Pruett-Miller SM, Spallek R, Bassermann F, Cheng Y, Schulman BA, Weiss MJ. FBXO11-Mediated Proteolysis of BAHD1 Relieves PRC2-dependent Transcriptional Repression in Erythropoiesis. Blood. Nov 6:blood.2020007809, 2020. doi: 10.1182/blood.2020007809. Online ahead of print. PMID: 33156908
Craig JE, Miller JN, Rayavarapu RR, Hong Z, Bulut GB, Zhuang W, Sakurada SM, Temirov J, Low JA, Chen T, Pruett-Miller SM, Huang LJ, Potts MB. MEKK3-MEK5-ERK5 signaling promotes mitochondrial degradation. Cell Death Discov Oct 20;6:107, 2020. doi: 10.1038/s41420-020-00342-7. eCollection 2020. PMID: 33101709
McGowan J, Peter C, Kim J, Popli S, Veerman B, Saul-McBeth J, Conti H, Pruett-Miller SM, Chattopadhyay S, Chakravarti R.14-3-3ζ-TRAF5 axis governs interleukin-17A signaling. Proc Natl Acad Sci U S A Oct 6;117(40):25008-25017, 2020. doi: 10.1073/pnas.2008214117. Epub Sep 23, 2020. PMID: 32968020
Demirci S, Zeng J, Wu Y, Uchida N, Shen AH, Pellin D, Gamer J, Yapundich M, Drysdale C, Bonanno J, Bonifacino AC, Krouse A, Linde NS, Engels T, Donahue RE, Haro-Mora JJ, Leonard A, Nassehi T, Luk K, Porter SN, Lazzarotto CR, Tsai SQ, Weiss M, Pruett-Miller SM, Wolfe SA, Bauer DE, Tisdale JF.BCL11A enhancer edited hematopoietic stem cells persist in rhesus monkeys without toxicity. J Clin Invest Sep 8:140189, 2020. doi: 10.1172/JCI140189. Online ahead of print. PMID: 32897878
Lee AK, Klein J, Fon Tacer K, Lord T, Oatley MJ, Oatley JM, Porter SN, Pruett-Miller SM, Tikhonova EB, Karamyshev AL, Wang YD, Yang P, Korff A, Kim HJ, Taylor JP, Potts PR. Translational Repression of G3BP in Cancer and Germ Cells Suppresses Stress Granules and Enhances Stress Tolerance. Mol Cell Aug 20;79(4):645-659.e9, 2020. doi: 10.1016/j.molcel.2020.06.037. Epub Jul 20, 2020. PMID: 32692974
Pinto EM, Figueiredo BC, Chen W, Galvao HCR, Formiga MN, Fragoso MCBV, Ashton-Prolla P, Ribeiro EMSF, Felix G, Costa TEB, Savage SA, Yeager M, Palmero EI, Volc S, Salvador H, Fuster-Soler JL, Lavarino C, Chantada G, Vaur D, Odone-Filho V, Brugières L, Else T, Stoffel EM, Maxwell KN, Achatz MI, Kowalski L, de Andrade KC, Pappo A, Letouze E, Latronico AC, Mendonca BB, Almeida MQ, Brondani VB, Bittar CM, Soares EWS, Mathias C, Ramos CRN, Machado M, Zhou W, Jones K, Vogt A, Klincha PP, Santiago KM, Komechen H, Paraizo MM, Parise IZS, Hamilton KV, Wang J, Rampersaud E, Clay MR, Murphy AJ, Lalli E, Nichols KE, Ribeiro RC, Rodriguez-Galindo C, Korbonits M, Zhang J, Thomas MG, Connelly JP, Pruett-Miller S, Diekmann Y, Neale G, Wu G, Zambetti. GPXAF1 as a modifier of p53 function and cancer susceptibility. Sci Adv Jun 24;6(26):eaba3231, 2020. doi: 10.1126/sciadv.aba3231. eCollection Jun 2020. PMID: 32637605
Nguyen P, Okeke E, Clay M, Haydar D, Justice J, O'Reilly C, Pruett-Miller S, Papizan J, Moore J, Zhou S, Throm R, Krenciute G, Gottschalk S, DeRenzo C.Route of 41BB/41BBL Costimulation Determines Effector Function of B7-H3-CAR.CD28ζ T Cells. Mol Ther Oncolytics Jun 23;18:202-214, 2020. doi: 10.1016/j.omto.2020.06.018. eCollection Sep 25, 2020. PMID: 32728609
Kesavardhana S, Malireddi RKS, Burton AR, Porter SN, Vogel P, Pruett-Miller SM, Kanneganti TD. The Zα2 domain of ZBP1 is a molecular switch regulating influenza-induced PANoptosis and perinatal lethality during development. J Biol Chem Jun 12;295(24):8325-8330, 2020. doi: 10.1074/jbc.RA120.013752. Epub Apr 29, 2020. PMID: 32350114
Mondal B, Jin H, Kallappagoudar S, Sedkov Y, Martinez T, Sentmanat MF, Poet GJ, Li C, Fan Y, Pruett-Miller SM, Herz HM.The histone deacetylase complex MiDAC regulates a neurodevelopmental gene expression program to control neurite outgrowth. Elife Apr 16;9:e57519, 2020. doi: 10.7554/eLife.57519. PMID: 32297854
Zeineldin M, Federico S, Chen X, Fan Y, Xu B, Stewart E, Zhou X, Jeon J, Griffiths L, Nguyen R, Norrie J, Easton J, Mulder H, Yergeau D, Liu Y, Wu J, Van Ryn C, Naranjo A, Hogarty MD, Kamiński MM, Valentine M, Pruett-Miller SM, Pappo A, Zhang J, Clay MR, Bahrami A, Vogel P, Lee S, Shelat A, Sarthy JF, Meers MP, George RE, Mardis ER, Wilson RK, Henikoff S, Downing JR, Dyer MA. MYCN amplification and ATRX mutations are incompatible in neuroblastoma. Nat Commun Feb 14;11(1):913, 2020. doi: 10.1038/s41467-020-14682-6. PMID: 32060267
**Pruett-Miller SM. Cancer Screens: Better Together. CRISPR J Feb;3(1):12-14, 2020. doi: 10.1089/crispr.2020.29084.spm. PMID: 32091251
Eom TY, Han SB, Kim J, Blundon JA, Wang YD, Yu J, Anderson K, Kaminski DB, Sakurada SM, Pruett-Miller SM, Horner L, Wagner B, Robinson CG, Eicholtz M, Rose DC, Zakharenko SS.Schizophrenia-related microdeletion causes defective ciliary motility and brain ventricle enlargement via microRNA-dependent mechanisms in mice. Nat Commun Feb 14;11(1):912, 2020. doi:10.1038/s41467-020-14628-y.PMID: 32060266
Yang SW, Li L, Connelly JP, Porter SN, Kodali K, Gan H, Park JM, Tacer KF, Tillman H, Peng J, Pruett-Miller SM, Li W, Potts PR. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex. Mol Cell Mar 19;77(6):1206-1221.e7, 2020. doi: 10.1016/j.molcel.2019.12.022. Epub Jan 21, 2020. PMID: 31980388
Métais JY, Doerfler PA, Mayuranathan T, Bauer DE, Fowler SC, Hsieh MM, Katta V, Keriwala S, Lazzarotto CR, Luk K, Neel MD, Perry SS, Peters ST, Porter SN, Ryu BY, Sharma A, Shea D, Tisdale JF, Uchida N, Wolfe SA, Woodard KJ, Wu Y, Yao Y, Zeng J, Pruett-Miller S, Tsai SQ, Weiss MJ. Genome editing of HBG1 and HBG2 to induce fetal hemoglobin. Blood Adv Nov 12;3(21):3379-3392, 2019. doi: 10.1182/bloodadvances.2019000820. PMID 31698466.
Porter SN, Levine RM, Pruett-Miller SM. A Practical Guide to Genome Editing Using Targeted Nuclease Technologies. Compr Physiol Mar 14;9(2):665-714, 2019. doi: 10.1002/cphy.c180022. PMID: 30873595
Connelly JP, Pruett-Miller SM. CRIS.py: A Versatile and High-throughput Analysis Program for CRISPR-based Genome Editing. Sci Rep Mar 12;9(1):4194, 2019. doi: 10.1038/s41598-019-40896-w.PMID: 30862905
Fon Tacer K, Montoya MC, Oatley MJ, Lord T, Oatley JM, Klein J, Ravichandran R, Tillman H, Kim M, Connelly JP, Pruett-Miller SM, Bookout AL, Binshtock E, Kamiński MM, Potts PR. MAGE cancer-testis antigens protect the mammalian germline under environmental stress. Sci Adv May 29;5(5):eaav4832, 2019. doi: 10.1126/sciadv.aav4832. eCollection May, 2019. PMID: 31149633
**Connelly JP, Pruett-Miller SM. CRIS.py: A Versatile and High-throughput Analysis Program for CRISPR-based Genome Editing. Sci Rep Mar 12;9(1):4194, 2019. doi: 10.1038/s41598-019-40896-w. PMID:30862905
Wang B, Maxwell BA, Joo JH, Gwon Y, Messing J, Mishra A, Shaw TI, Ward AL, Quan H, Sakurada SM, Pruett-Miller SM, Bertorini T, Vogel P, Kim HJ, Peng J, Taylor JP, Kundu M. ULK1 and ULK2 Regulate Stress Granule Disassembly Through Phosphorylation and Activation of VCP/p97. Mol Cell May 16;74(4):742-757.e8, 2019. doi: 10.1016/j.molcel.2019.03.027. Epub Apr 9, 2019. PMID: 30979586
Waghulde H, Cheng X, Galla S, Mell B, Cai J, Pruett-Miller SM, Vazquez G, Patterson A, Vijay Kumar M, Joe B. Attenuation of Microbiotal Dysbiosis and Hypertension in a CRISPR/Cas9 Gene Ablation Rat Model of GPER1. Hypertension Nov;72(5):1125-1132, 2018. doi: 10.1161/HYPERTENSIONAHA.118.11175. PMID: 30354811
**Chen YH, Pruett-Miller SM. Improving single-cell cloning workflow for gene editing in human pluripotent stem cells. Stem Cell Res Aug;31:186-192, 2018. doi: 10.1016/j.scr.2018.08.003. Epub 2018 Aug 4. PMID:30099335
Wang B, Joo JH, Mount R, Teubner BJW, Krenzer A, Ward AL, Ichhaporia VP, Adams EJ, Khoriaty R, Peters ST, Pruett-Miller SM, Zakharenko SS, Ginsburg D, Kundu M. The COPII cargo adapter SEC24C is essential for neuronal homeostasis. J Clin Invest Aug 1;128(8):3319-3332, 2018. doi: 10.1172/JCI98194. Epub 2018 Jun 25. PMID: 29939162
Churchman ML, Qian M, Te Kronnie G, Zhang R, Yang W, Zhang H, Lana T, Tedrick P, Baskin R, Verbist K, Peters JL, Devidas M, Larsen E, Moore IM, Gu Z, Qu C, Yoshihara H, Porter SN, Pruett-Miller SM, Wu G, Raetz E, Martin PL, Bowman WP, Winick N, Mardis E, Fulton R, Stanulla M, Evans WE, Relling MV, Pui CH, Hunger SP, Loh ML, Handgretinger R, Nichols KE, Yang JJ, Mullighan CG.Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia. Cancer Cell May 14;33(5):937-948.e8, 2018. doi: 10.1016/j.ccell.2018.03.021. Epub 2018 Apr 19.PMID: 29681510
**Pruett-Miller SM. It's CRISPR Clear: Off-Target Study Misses the Mark. CRISPR J Apr;1:130-131, 2018. doi: 10.1089/crispr.2018.29013.mil. PMID:31021203
Stewart DP, Marada S, Bodeen WJ, Truong A, Sakurada SM, Pandit T, Pruett-Miller SM, Ogden SK.Cleavage activates dispatched for Sonic Hedgehog ligand release. Elife Jan 23;7, 2018. pii: e31678. doi: 10.7554/eLife.31678. PMID: 29359685
**Sentmanat MF, Peters ST, Florian CP, Connelly JP, Pruett-Miller SM. A Survey of Validation Strategies for CRISPR-Cas9 Editing. Sci Rep Jan 17;8(1):888, 2018. doi: 10.1038/s41598-018-19441-8. PMID: 29343825
Cheng X, Waghulde H, Mell B, Morgan EE, Pruett-Miller SM, Joe B. Positional cloning of quantitative trait nucleotides for blood pressure and cardiac QT-interval by targeted CRISPR/Cas9 editing of a novel long non-coding RNA. PLoS Genet Aug 21;13(8):e1006961, 2017. doi: 10.1371/journal.pgen.1006961. eCollection 2017 Aug. PMID: 28827789
Wen Y, Liao G, Pritchard T, Zhao TT, Connelly JP, Pruett-Miller SM, Blanc V, Davidson NO, Madison BB. A Stable but Reversible Integrated Surrogate Reporter for Assaying CRISPR/Cas9-Stimulated Homology-directed Repair. J Biol Chem Apr 14;292(15):6148-6162, 2017. doi: 10.1074/jbc.M117.777722. Epub 2017 Feb 22. PMID: 28228480
Cohen AJ, Saiakhova A, Corradin O, Luppino JM, Lovrenert K, Bartels CF, Morrow JJ, Mack SC, Dhillon G, Beard L, Myeroff L, Kalady MF, Willis J, Bradner JE, Keri RA, Berger NA, Pruett-Miller SM, Markowitz SD, Scacheri PC. Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenome. Nat Commun Feb 7;8:14400, 2017. doi: 10.1038/ncomms14400. PMID: 28169291
Orchard RC, Wilen CB, Doench JG, Baldridge MT, McCune BT, Lee YC, Lee S, Pruett-Miller SM, Nelson CA, Fremont DH, Virgin HW. Discovery of a proteinaceous cellular receptor for a norovirus. Science Aug 26; 353(6302):933-6, 2016. doi: 10.1126/science.aaf1220. Epub 2016 Aug 18. PubMed PMID: 27540007
Redmann V, Lamb CA, Hwang S, Orchard RC, Kim S, Razi M, Milam A, Park S, Yokoyama CC, Kambal A, Kreamalmeyer D, Bosch MK, Xiao M, Green K, Kim J, Pruett-Miller SM, Ornitz DM, Allen PM, Beatty WL, Schmidt RE, DiAntonio A, Tooze SA, Virgin HW. Clec16a is Critical for Autolysosome Function and Purkinje Cell Survival. Sci Rep 6:23326, 2016. PMID: 26987296
*Pruett-Miller SM, Davis GD. Donor plasmid design for codon and single base genome editing using zinc finger nucleases. Method Mol Bio 1239:219-29, 2015. PMID: 25408411
Chen F, Pruett-Miller SM, Davis GD. Gene editing using ssODNs with engineered endonucleases. Methods Mol Bio 1239:251-65, 2015. PMID: 25408408
Duda K, Lonowski LA, Kofoed-Nielsen M, Ibarra A, Delay CM, Kang Q, Yang Z, Pruett-Miller SM, Bennett EP, Wandall HH, Davis GD, Hansen SH, Frodin M. High-efficiency genome editing via 2A-coupled co-expression of fluorescent proteins and zinc finger nucleases of CRISPR/Cas9 nickase pairs. Nucleic Acids Research Jun;42(10):e84. doi: 10.1093/nar/gku251, 2014. Epub 2014 Apr 21.PMID: 24753413
Voit RA, Hendel A, Pruett-Miller SM, Porteus MH. Nuclease-mediated gene editing by homologous recombination of the human globin locus. Nucleic Acids Research Jan;42(2):1365-78, 2014. doi: 10.1093/nar/gkt947. Epub 2013 Oct 23. PMID: 24157834
Wilson KA, McEwen AE, Pruett-Miller SM, Zhang J, Kildebeck EJ, Porteus MH. Expanding the Repertoire of target sites for zinc finger nuclease-mediated genome modification. Molecular Therapy Nucleic Acids 2:e88, 2013. PMID: 23632390
Chen F, Pruett-Miller SM, Huang Y, Gjoka M, Duda K, Taunton J, Frodin M, Davis GD. High Frequency Genome Editing Using ssDNA with Zinc Finger Nucleases. Nature Methods Jul 17;8(9):753-5, 2011. doi: 10.1038/nmeth.1653. PMID: 21765410
Davis GD, Pruett-Miller SM. ZFN Donor Design; Codon and Single Base Genome Editing Using Zinc Finger Nucleases. Biowire 39-43, 2010.
Connelly JP, Barker JC, Pruett-Miller S, Porteus MH. Gene Correction by Homologous Recombination with Zinc Finger Nucleases in Primary Cells from a Mouse Model of a Generic Recessive Genetic Disease. Molecular Therapy Jun;18(6):1103-10, 2010. doi: 10.1038/mt.2010.57. Epub 2010 Apr 13. PMID: 20389291
Zou J, Maeder ML, Mali P, Pruett-Miller SM, Thibodeau-Beganny S, Chou BK, Chen G, Ye Z, Park IH, Daley GQ, Porteus MH, Joung JK, Cheng L. Gene Targeting of a Disease-related Gene in Human Induced Pluripotent Stem and Embryonic Cells. Cell Stem Cell Jul 2;5(1):97-110, 2009. doi: 10.1016/j.stem.2009.05.023. Epub 2009 Jun 18. PMID: 19540188
*Pruett-Miller SM, Reading D, Porter SN, Porteus MH. Attenuation of Zinc Finger Nuclease Cytotoxicity by Regulating Protein Expression. PLoS Genetics Feb;5(2):e1000376, 2009. doi: 10.1371/journal.pgen.1000376. Epub 2009 Feb 13. PMID: 19214211
Maeder ML, Thibodeau-Beganny S, Osiak A, Wright DA, Anthony RM, Eichtinger M, Jiang T, Foley JE, Winfrey RF, Townsend JA, Unger-Wallace E, Sander JD, Muller-Lerch Felix, Pearlberg J, Gobel C, Dassie JP, Pruett-Miller SM, Porteus MH, Sgroi DC, Iafrate AJ, Dobbs D, McCray PB, Cathomen T, Voytas DF, Joung JK. Efficient Gene Modification Enabled by an OPEN (Oligomerized Pool ENgineering) Platform for Constructing Zinc Finger Nucleases. Molecular Cell Jul 25;31(2):294-301, 2008. doi: 10.1016/j.molcel.2008.06.016. PMID: 18657511
*Pruett-Miller SM, Connelly JP, Maeder ML, Joung JK, Porteus MH. Comparison of zinc finger nucleases for use in gene targeting in mammalian cells. Molecular Therapy 707-717, 2008. doi: 10.1038/mt.2008.20. Epub 2008 Mar 4. PMID: 18334988
Porteus MH, Connelly JP, Pruett SM. A Look to the Future Directions in Gene Therapy Research for Monogenic Diseases. PLOS Genetics 1285-1292, 2006. PMID: 17009872
Last update: January 2024